4//SEC Filing
Stanley Rhonda L. 4
Accession 0001566045-19-000004
CIK 0000737207other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 2:42 PM ET
Size
6.1 KB
Accession
0001566045-19-000004
Insider Transaction Report
Form 4
Stanley Rhonda L.
SVP Finance & Accounting
Transactions
- Award
Options to purchase common stock
2019-11-01+350,000→ 350,000 totalExercise: $0.09Exp: 2029-11-01→ common stock (350,000 underlying)
Footnotes (1)
- [F1]Options to purchase 75,000 shares are exercisable immediately, options to purchase 75,000 shares shall vest on each of November 1, 2020, November 1, 2021 and November 1, 2022, options to purchase 25,000 shares shall vest on such date (if any) that the Issuer determines that the "Revenue Target" (as defined in the Employment Agreement dated October 29, 2019 between the Issuer and the reporting person (the "Employment Agreement")) is achieved, and options to purchase 25,000 shares shall vest on such date (if any) that the Issuer determines that the "Stock Price Target" (as defined in the Employment Agreement) has been achieved.
Documents
Issuer
Adhera Therapeutics, Inc.
CIK 0000737207
Entity typeother
Related Parties
1- filerCIK 0001566045
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 2:42 PM ET
- Size
- 6.1 KB